MILWAUKEE, May 1, 2023 /PRNewswire/ — Ademi LLP is investigating Satsuma STSA for possible breaches of fiduciary duty and other violations of law in its transaction with Shin Nippon. Click here to learn how to join the action https://www.ademilaw.com/case/satsuma-pharmaceuticals-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost…Read More
Shareholder Alert Ademi LLP investigates whether Satsuma Pharmaceuticals Inc has obtained a Fair Price in its transaction with Shin Nippon Satsuma Pharma NASDAQSTSA
